An anticipated increase in the number of people with dementia will lead to an escalation in health and so- cial care spending unless it is altered by a major break- through in treatment or prevention. Behavioral symp- toms associated with dementia (BSD) are some of the most difficult problems faced by caregivers. Several measurement issues have hampered the progress of timely intervention for BSD. Sensor technology may offer a solution to the early detection of BSD that will guide the development of tailored interventions. Simi- larly, a clinical conceptualization of BSD and its mea- surement issues can facilitate the engineering of sensor networks and algorithms for activity recognition. Multi- disciplinary collaboration and the consideration of eth- ical issues will improve the adoption of these technolo- gies in healthcare research.
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
A Case for Using Sensor Technology to Monitor Disruptive Behavior of Persons With Dementia
1. A Case for
Using Sensor Technology to
Monitor Disruptive Behaviors
of Persons with Dementia
Maria Yefimova & Diana Lynn Woods
UCLA School of Nursing
November 3, 2012
2012 AAAI Fall Symposium: AI for Gerontechnology 1
2. Overview
Behavioral Symptoms of Dementia
Definition
Measurement Issues
Sensor Networks
Sensor Selection
Data Processing Algorithms
Meaningful Output
Ethics of Technology
Future Research 2
3. Population of Interest
35.6 million people worldwide (Wimo & Prince, 2010)
Affected by dementia - Alzheimer’s disease
most common
Progressive memory loss
Need help with daily activities
“Disruptive behaviors” (BSD)
Cost of care $604 billion, more than 1% GDP
(Wimo & Prince, 2010)
3
4. Problem of Interest
“Behavioral Symptoms of Dementia” (BSD)
Challenging to care providers
Consume time and effort
Unsafe, resulting in accidents
Lead to institutionalization
Increase cost of care
4
6. Goal of Research on BSD
Inform clinical practice on prevention and
management through
Identifying high risk individuals
Predicting escalation of behavior
Timing is crucial for interventions
Developing individualized plans
6
7. Challenges and Opportunities
Heterogeneous population
Within-individual variability of behavior and
response
Data is costly and difficult to analyze
BSD manifestation
Behaviors vary in intensity, cluster together
Non-linear patterns of escalation/de-escalation
Can technology provide new tools to study BSD?
7
9. Deploying Sensor Networks
Multimodal sensors to capture all aspects of
behavior
E.g. agitation recognition rate - 59% ultrasonic alone,
73% with pressure, up to 94% with sensor fusion
(Biswas, Jayachandran & Thang, 2006)
Sensors Behavior
Motion Restlessness
Radar Tapping/Banging
GPS tracking Wandering
Acoustic Vocalization
Pressure (bed) Sleep disturbances
Video Daily Activities 9
10. Technical Considerations
Wearable
Specific to individual, mobile
Size and placement must be tolerated
Environmental
Unobtrusive and more acceptable
Static position, tied to specific environment
Wired versus Wireless
Power consumption and battery life, cable
management
10
11. Data Processing
Algorithms chosen based on assumptions about
behavior
Well-defined sequences of events (eg. ADLs)
Decision trees with classifiers (Maurer et al., 2007),
temporal logic models (Rugnone et al., 2007)
Sporadic and variable (eg. BSD)
Fuzzy logic (Fook, 2007), Bayesian models (Biswas,
Jayachandran & Thang, 2006)
Goal: activity recognition and prediction
11
12. Algorithm Considerations
Obtaining “baseline” to recognize deviations
Learning data can’t be modeled in lab setting
Not generalizable across individuals (Algase et al., 2010)
Inferring meaning
Timing and micro-context (Biswas et al., 2010)
Information about surrounding environment
12
13. Meaningful Output
Output readable by end user (researchers,
clinicians, caregivers)
Visual representation of data
Clinically relevant time intervals
Validation against “ground truth”
Direct observation by experienced clinicians
Caution in using existing scales and measures
13
14. Ethical Issues
Monitoring may be perceived as
“intrusive surveillance” (Price 2007)
Moderated by perception of technology
From older adult and caregiver/family
Consent with the cognitively impaired
Proxy consent
Preserve privacy and safety of information
14
15. Future Direction
Currently limited to small samples
Feasibility studies in labs, with non-elders
Translating to “real world” setting
Potential to use in evaluating interventions
Financial and human capital considerations
Cost-benefit analysis
15
16. Conclusion
Collaboration between clinicians and
developers
Learning a new, common “language”
Technology as a research tool
To understand the phenomenon
To evaluate interventions
Goal: improving health of vulnerable older
adults and reducing healthcare costs
16
17. Questions? Suggestions?
m.yefimova@ucla.edu
Supported by
John A. Hartford Foundation’s
National Hartford Centers of Gerontological
Nursing Excellence
Award Program 17
Editor's Notes
Hello all. Thank you for this opportunity to present
Developing assistive technology for older adults has been a hot topic for a while. Its goal was to create tools for independent living and health improvement that would bring down the cost of associate health care. Not all older adults have the same need. Here we will focus on a subpopulation of vulnerable elders. Currently there are 35.6 million people worldwide affected by Dementia according to the 2010 Alz report. It is a condition characterized by progressive memory loss. Over time - months, years, decades – the person loses their memory, at first forgetting where they put their glasses, and then forgetting how to brush their teeth and feed themselves. Ultimately they rely on others to function. The caregiver may be their family or a health care professional. In addition to decline of their cognitive abilities, the person with dementia may exhibit so-called “disruptive behaviors” or BSD (behavioral symptoms of dementia) which further increase burden of care. Caring for individuals with dementia takes enormous amounts of effort, time and money and the cost of care has been estimate to be more than 1% of world’s GDP.